ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization

• Published in: Catheterization and cardiovascular interventions 2012-09, Vol.80 (3), p.E50-E81
• Main Authors: Patel, Manesh R., Bailey, Steven R., Bonow, Robert O., Chambers, Charles E., Chan, Paul S., Dehmer, Gregory J., Kirtane, Ajay J., Wann, L. Samuel, Ward, R. Parker, Douglas, Pamela S., Altus, Philip, Barnard, Denise D., Blankenship, James C., Casey Jr, Donald E., Dean, Larry S., Fazel, Reza, Gilchrist, Ian C., Kavinsky, Clifford J., Lakoski, Susan G., Le, D. Elizabeth, Lesser, John R., Levine, Glenn N., Mehran, Roxana, Russo, Andrea M., Sorrentino, Matthew J., Williams, Mathew R., Wong, John B., Wolk, Michael J., Hendel, Robert C., Kramer, Christopher M., Min, James K., Shaw, Leslee, Stainback, Raymond F., Allen, Joseph M.
• Format: Article
• Language: English
• Subjects: ACCF Appropriate Use Criteria; angiography; catheterization; coronary artery disease; valvular disease
• ISSN: 1522-1946; 1522-726X
• DOI: 10.1002/ccd.24467

The American College of Cardiology Foundation, in collaboration with the Society for Cardiovascular Angiography and Interventions and key specialty and subspecialty societies, conducted a review of common clinical scenarios where diagnostic catheterization is frequently considered. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of studies examining the implementation of noninvasive imaging appropriate use criteria. The 166 indications in this document were developed by a diverse writing group and scored by a separate independent technical panel on a scale of 1 to 9, to designate appropriate use (median 7 to 9), uncertain use (median 4 to 6), and inappropriate use (median 1 to 3). Diagnostic catheterization may include several different procedure components. The indications developed focused primarily on 2 aspects of diagnostic catheterization. Many indications focused on the performance of coronary angiography for the detection of coronary artery disease with other procedure components (e.g., hemodynamic measurements, ventriculography) at the discretion of the operator. The majority of the remaining indications focused on hemodynamic measurements to evaluate valvular heart disease, pulmonary hypertension, cardiomyopathy, and other conditions, with the use of coronary angiography at the discretion of the operator. Seventy‐five indications were rated as appropriate, 49 were rated as uncertain, and 42 were rated as inappropriate. The appropriate use criteria for diagnostic catheterization have the potential to impact physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of uncertain clinical scenarios facilitates identification of areas that would benefit from future research. © 2012 Wiley Periodicals, Inc.